240 related articles for article (PubMed ID: 28323033)
1. Application of mathematical models to metronomic chemotherapy: What can be inferred from minimal parameterized models?
Ledzewicz U; Schättler H
Cancer Lett; 2017 Aug; 401():74-80. PubMed ID: 28323033
[TBL] [Abstract][Full Text] [Related]
2. Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy.
Schättler H; Ledzewicz U; Amini B
J Math Biol; 2016 Apr; 72(5):1255-80. PubMed ID: 26089097
[TBL] [Abstract][Full Text] [Related]
3. A mathematical model to study low-dose metronomic scheduling for chemotherapy.
Arora G; Bairagi N; Chatterjee S
Math Biosci; 2024 Jun; 372():109186. PubMed ID: 38580078
[TBL] [Abstract][Full Text] [Related]
4. Metronomics chemotherapy: time for computational decision support.
Barbolosi D; Ciccolini J; Meille C; Elharrar X; Faivre C; Lacarelle B; André N; Barlesi F
Cancer Chemother Pharmacol; 2014 Sep; 74(3):647-52. PubMed ID: 25082520
[TBL] [Abstract][Full Text] [Related]
5. Metronomic chemotherapy and immunotherapy in cancer treatment.
Chen YL; Chang MC; Cheng WF
Cancer Lett; 2017 Aug; 400():282-292. PubMed ID: 28189534
[TBL] [Abstract][Full Text] [Related]
6. Metronomic reloaded: Theoretical models bringing chemotherapy into the era of precision medicine.
Benzekry S; Pasquier E; Barbolosi D; Lacarelle B; Barlési F; André N; Ciccolini J
Semin Cancer Biol; 2015 Dec; 35():53-61. PubMed ID: 26361213
[TBL] [Abstract][Full Text] [Related]
7. Metronomic chemotherapy for advanced breast cancer patients.
Cazzaniga ME; Dionisio MR; Riva F
Cancer Lett; 2017 Aug; 400():252-258. PubMed ID: 28017894
[TBL] [Abstract][Full Text] [Related]
8. Dynamics and control of a mathematical model for metronomic chemotherapy.
Ledzewicz U; Amini B; Schättler H
Math Biosci Eng; 2015 Dec; 12(6):1257-75. PubMed ID: 26775862
[TBL] [Abstract][Full Text] [Related]
9. Metronomic chemotherapy: A potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activation.
Biziota E; Mavroeidis L; Hatzimichael E; Pappas P
Cancer Lett; 2017 Aug; 400():243-251. PubMed ID: 28017892
[TBL] [Abstract][Full Text] [Related]
10. On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach.
Ledzewicz U; Wang S; Schattler H; Andre N; Heng MA; Pasquier E
Math Biosci Eng; 2017 Feb; 14(1):217-235. PubMed ID: 27879129
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling.
Bodzioch M; Bajger P; Foryś U
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2281-2299. PubMed ID: 34050795
[TBL] [Abstract][Full Text] [Related]
12. Metronomic chemotherapy and nanocarrier platforms.
Abu Lila AS; Ishida T
Cancer Lett; 2017 Aug; 400():232-242. PubMed ID: 27838415
[TBL] [Abstract][Full Text] [Related]
13. Role of vascular normalization in benefit from metronomic chemotherapy.
Mpekris F; Baish JW; Stylianopoulos T; Jain RK
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1994-1999. PubMed ID: 28174262
[TBL] [Abstract][Full Text] [Related]
14. Metronomic chemotherapy in metastatic colorectal cancer.
Woo IS; Jung YH
Cancer Lett; 2017 Aug; 400():319-324. PubMed ID: 28274890
[TBL] [Abstract][Full Text] [Related]
15. Tumor endothelial cells as a potential target of metronomic chemotherapy.
Kim JY; Kim YM
Arch Pharm Res; 2019 Jan; 42(1):1-13. PubMed ID: 30604201
[TBL] [Abstract][Full Text] [Related]
16. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
Kerbel RS; Shaked Y
Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
[TBL] [Abstract][Full Text] [Related]
17. ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy.
Hida K; Kikuchi H; Maishi N; Hida Y
Cancer Lett; 2017 Aug; 400():305-310. PubMed ID: 28216371
[TBL] [Abstract][Full Text] [Related]
18. Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance.
Kareva I; Waxman DJ; Lakka Klement G
Cancer Lett; 2015 Mar; 358(2):100-106. PubMed ID: 25541061
[TBL] [Abstract][Full Text] [Related]
19. [Metronomic chemotherapy in pediatric oncology: hype or hope?].
André N; Pasquier E; Verschuur A; Sterba J; Gentet JC; Rössler J
Arch Pediatr; 2009 Aug; 16(8):1158-65. PubMed ID: 19446445
[TBL] [Abstract][Full Text] [Related]
20. Metronomic chemotherapy from rationale to clinical studies: a dream or reality?
Gnoni A; Silvestris N; Licchetta A; Santini D; Scartozzi M; Ria R; Pisconti S; Petrelli F; Vacca A; Lorusso V
Crit Rev Oncol Hematol; 2015 Jul; 95(1):46-61. PubMed ID: 25656744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
